ORIONIS BIOSCIENCES
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation. The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initial internal focus in oncology and immunotherapies. Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.
ORIONIS BIOSCIENCES
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2015-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.orionisbio.com
Total Employee:
11+
Status:
Active
Total Funding:
24.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Google Maps Yoast SEO Premium Yoast Plugins
Similar Organizations
BALX Holdings
Balx Holdings operates in the healthcare industry focusing on biotechnology business.
Cannara Biotech
Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.
Centrexion
Centrexion operates in the healthcare industry, focusing on the biotechnology business.
Functional Fluidics
Functional Fluidics specializes in the standardization of clinical blood function assays to assess individual patient response.
Karuna Health
Karuna connects patients with healthcare guides through streamlined communication and automation.
Nido Biosciences
Nido Biosciences currently operates in healthcare services.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Rocket Pharmaceuticals
Rocket Pharmaceuticals Ltd. operates in the healthcare industry focusing on biotechnology business.
Sidero Bioscience
Sidero Bioscience operates in the healthcare industry focusing on biotechnology business.
Sunbeam
Sunbeam Holdings, L.P. operates in the healthcare industry. Sunbeam Holdings, L.P. was incorporated in 2007 and is based in Sunrise,
Symic Biomedical
SYMIC Biomedical operates in the healthcare industry focusing on biotechnology business.
Vetica Labs
Vetica Labs is operates in the healthcare industry focusing on biotechnology business.
Current Employees Featured
Nikolai Kley Founder, President and CEO @ Orionis Biosciences
Founder, President and CEO
2015-01-01
James Kyranos Vice President, Technical Operations @ Orionis Biosciences
Vice President, Technical Operations
2016-01-01
Matias de Tezanos Investor & Board Director @ Orionis Biosciences
Investor & Board Director
2018-03-01
Andrew Littlehall Vice President Finance @ Orionis Biosciences
Vice President Finance
2018-10-01
Founder
Investors List
Excel Venture Management
Excel Venture Management investment in Private Equity Round - Orionis Biosciences
CB Health Ventures
CB Health Ventures investment in Private Equity Round - Orionis Biosciences
Solasta Ventures
Solasta Ventures investment in Series B - Orionis Biosciences
V-Bio Ventures
V-Bio Ventures investment in Series B - Orionis Biosciences
Empire Angels
Empire Angels investment in Series B - Orionis Biosciences
Matias de Tezanos
Matias de Tezanos investment in Venture Round - Orionis Biosciences
V-Bio Ventures
V-Bio Ventures investment in Series A - Orionis Biosciences
Official Site Inspections
http://www.orionisbio.com
- Host name: 126.25.167.72.host.secureserver.net
- IP address: 72.167.25.126
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Orionis Biosciences"
About Us - Orionis Biosciences
During his tenure at Macrolide, Andy helped lead the company from early stage proof of concept to a development stage organization. He was responsible for strategic planning and capital creation, and he played a key role in two equity …See details»
Precision through target visibility and tunable design
Nov 15, 2023 Engaging the powers of nature with precision drug design Tough targets. New modalities. New possibilities. Orionis is a clinical-stage life sciences company developing conditionally acting medicines for cancer and other …See details»
Orionis Biosciences - Crunchbase Company Profile
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation. The company is an early-stage drug …See details»
Orionis Biosciences - LinkedIn
Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities.See details»
Orionis Biosciences Information - RocketReach
Orionisbio.com; eni.com; 2 415481XXXX; 39348335XXXX; View Similar People. Related Companies ARP American Research Products, Inc. 4 $1m Bird Precision, Inc. 8 $5.2m …See details»
Orionis Biosciences Company Overview, Contact Details
Oct 19, 2022 Orionis Biosciences Inc launches cis-targeted interferon immunotherapy. November 15, 2023, BOSTON, MA, and GHENT, Belgium - Orionis Biosciences, a life …See details»
Orionis Biosciences 2025 Company Profile: Valuation, Funding ...
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; EP-4476254-A2: Il-2 trap molecules: Pending: 10-Feb-2022: EP-4408479-A1: Split human ifn-gamma and tnf …See details»
Orionis Biosciences - Craft
Orionis Biosciences has 5 employees across 2 locations and $23.7 m in total funding,. See insights on Orionis Biosciences including office locations, competitors, revenue, financials, …See details»
Orionis Biosciences - VentureRadar
"Orionis Biosciences is a life sciences company pioneering technological innovations in genome-scale drug discovery to develop novel, highly specific and tunable therapeutics for cancer and …See details»
Orionis Biosciences - Work in biotech
Orionis Biosciences is a genome-scale drug-discovery and development company using innovative technologies for cancer and other diseases. To facilitate selective engagement with …See details»
Orionis Biosciences - Overview, News & Similar companies
Nov 14, 2023 Orionis Biosciences Announces First Patient Dosed in Phase 1 Clinical Trial of ORB-011 in Patients with Advanced Solid Tumors BOSTON & GHENT, Belgium--(BUSINESS …See details»
Orionis Biosciences Staff Directory & Email Format - ContactOut
Explore Orionis Biosciences staff directory for direct access to contact details on 38 employees including email format, email address and phone numbers.See details»
Approach in drug discovery - Orionis Biosciences
Our programs target multiple stages and components of the CIC to restore immune attack against cancer – from detection of cancer cells to promoters of tumor antigen processing, T and NK …See details»
Orionis Biosciences Company Profile: Overview and Full News …
Orionisbio.com. Life Sciences. Overview: Orionis Biosciences. Orionis Biosciences is a clinical-stage life sciences company based in Massachusetts, specializing in developing conditionally …See details»
Orionis Biosciences - LinkedIn
Orionis Biosciences | 3,351 followers on LinkedIn. Precision through target visibility and tunable design | Orionis Biosciences is a life sciences company pioneering technological innovation in …See details»
Genentech Partners with Orionis Biosciences to Discover and …
On Sept. 20, 2023, Orionis Biosciences, a privately held US-based life sciences company with an integrated drug discovery and chemical biology platform, announced that it has entered into a …See details»
Platforms - Orionis Biosciences
Orionis has developed two transformative technology platforms. While technologically distinct, addressing small and large molecules, they both harness proximity and cooperativity …See details»
Orionis Biosciences Debuts with Major Pharmaceutical …
Mar 5, 2020 Madeline Davidshofer MacDougall press@orionisbio.com 781-235-3060 Release Summary. Orionis Biosciences is today debuting with the announcement of a major drug …See details»
Orionis Biosciences Announces First Patient Dosed in Phase 1 …
Nov 15, 2023 The company is advancing a deep and diversified pipeline of drug modalities, including agents that engage components of the adaptive and innate immune systems, …See details»
Organisation vs. Organization: What’s the Difference?
The US nuclear base at Incirlik is a key part of western defences; were Turkey to leave the organisation its loss would be a serious blow. –The Telegraph Gianforte said the $50,000 …See details»